MENU
ACET
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Adicet Bio (ACET) Earnings Date & Reports

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases... Show more

A.I. Advisor
published Earnings

ACET is expected to report earnings to fall 33.07% to -19 cents per share on March 05

Adicet Bio ACET Stock Earnings Reports
Q4'25
Est.
$-0.19
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.03
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.03
The last earnings report on November 05 showed earnings per share of -28 cents, beating the estimate of -30 cents. With 1.63M shares outstanding, the current market capitalization sits at 101.62M.
View a ticker or compare two or three
ACET
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACET showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a distributor of pharmaceutical intermediate ingrediants and other industrial chemicals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Distributors
Address
131 Dartmouth Street
Phone
+1 650 503-9095
Employees
143
Web
https://www.adicetbio.com